Centrus is the only listed US supplier of enriched uranium, with a $3.6B backlog and $833M cash. Read why LEU stock is a Buy ...

Gilead Sciences remains a long-term Buy due to solid quarterly results, raised guidance, and continued strength in its HIV ...

Abacus Global Management's baby bonds yield nearly 10%, but this high yield reflects significant underlying risks. Read why ...

DaVita (DVA) faces economic challenges with subpar returns, limited growth, and declining fair value amidst restructuring.

GMO’s 13F portfolio grew to $33.23B in Q2 2025, with Microsoft, Meta, Alphabet, Oracle, and Apple as top holdings. Read more ...

Lithium Argentina has strong short-term production growth potential. Ramping up output and a price rebound could quickly ...

Amer Sports' impressive 23% revenue growth in Q2 was driven by Salomon and Arc'teryx. Store expansion has shifted the channel ...

Gro's core lawn and garden business shows resilience with positive consumer sales. Read why SMG stock is upgraded to Buy.

La-Z-Boy Incorporated Q1 earnings missed expectations, but strong cash reserves and expansion plans support long-term growth.

AEF offers unique emerging market exposure, excluding China. Learn about the closed-end fund's policy changes, new benchmarks ...

Two Harbors Investment (TWO) agreed to pay $375M to settle all litigation related to terminating its management agreement ...

Lowe's faces falling sales post-pandemic but maintains strong margins and earnings through aggressive buybacks and M&A. Learn ...